Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Foly-5
- Development stage
- Unknown
- Lead developer
- Drug International
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Foly-5 is a branded generic pharmaceutical product developed and manufactured by Kaiser Pharmaceutical. It contains 5 mg of folic acid, a synthetic form of the water-soluble B-vitamin folate (Vitamin B9). Folic acid is essential for the synthesis of nucleosides, the methylation of DNA, and the metabolism of amino acids. It plays a critical role in rapid cell division and growth, particularly during infancy and pregnancy. Foly-5 is indicated for the treatment of megaloblastic and macrocytic anemias due to folate deficiency and is used prophylactically during pregnancy to prevent neural tube defects such as spina bifida. It is also used in patients with malabsorption syndromes or those taking folate-depleting medications.
- Brand names
- Foly-5Foly5Foly 5
- Other names
- Folic acidVitamin B9
02
Targets
DHFR (Dihydrofolate reductase)FOLR1 (FRα)
Beyond the preview
Go deeper on Foly-5.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Foly-5.